POST-STUDY TREATMENT OPTIONS ARE LIMITED IN PATIENTS WITH ADVANCED NET: ANALYSIS OF POST-PROGRESSION THERAPIES FROM THE RADIANT-2 TRIAL | AVESİS

Hacettepe University Research Information System

POST-STUDY TREATMENT OPTIONS ARE LIMITED IN PATIENTS WITH ADVANCED NET: ANALYSIS OF POST-PROGRESSION THERAPIES FROM THE RADIANT-2 TRIAL

Copy For Citation

Peeters M., Becerra C., Panneerselvam A., Saletan S., YALÇIN Ş.

European-Society-for-Medical-Oncology (ESMO) 13th World Congress on Gastrointestinal Cancer, Barcelona, Spain, 22 - 25 June 2011, vol.22

Publication Type: Conference Paper / Summary Text
Volume: 22
City: Barcelona
Country: Spain
Hacettepe University Affiliated: Yes